Ceclobid Indications/Uses

Cefaclor is a cephalosporin antibiotic administered by mouth similarly to Cefalexin in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Lower respiratory tract infections, including pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis caused by S. pneumoniae, H. influenzae, Staphylococci, S. pyogenes (group A β-hemolytic streptococci), and M. catarrhalis.
Upper respiratory infections, including pharyngitis and tonsillitis, caused by S. pyogenes (group A β-hemolytic streptococci), and M. catarrhalis.
Urinary tract infections, including pyelonephritis and cystitis, caused by E. coli, P. mirabilis, Klebsiella spp. and coagulase-negative Staphylococci.
Note: Cefaclor has been found to be effective in both acute and chronic urinary tract infections.
Skin and soft tissue infections caused by Staphylococcus aureus and S. pyogenes (group A β-hemolytic streptococci).
Otitis media caused by S. pneumoniae, H. influenzae, Staphylococci, S. pyogenes (group A β-hemolytic streptococci), and M. catarrhalis.
Cefaclor is classified as a second generation cephalosporin and its greater activity against Haemophilus influenzae makes it more suitable than cephalexin for the treatment of infections such as otitis media.
Sinusitis.
Gonococcal urethritis: Appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to Cefaclor.